About CorMedix
CorMedix is a company based in Bridgewater (United States) founded in 2006.. CorMedix has raised $2.62 million across 3 funding rounds from investors including HHS. The company has 65 employees as of December 31, 2024. CorMedix has completed 1 acquisition, including Melinta Therapeutics.
- Headquarter Bridgewater, United States
- Employees 65 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cormedix Inc.
-
Annual Revenue
$43.47 M0as on Dec 31, 2024
-
Net Profit
$-17.93 M61.31as on Dec 31, 2024
-
EBITDA
$-21.9 M55.08as on Dec 31, 2024
-
Total Equity Funding
$2.62 M (USD)
in 3 rounds
-
Latest Funding Round
$274.47 K (USD), Grant
Aug 15, 2017
- Investors
-
Employee Count
65
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CorMedix
CorMedix is a publicly listed company on the NASDAQ with ticker symbol CRMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of CorMedix
CorMedix has successfully raised a total of $2.62M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $274.47 thousand completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $274,469
-
First Round
First Round
(12 Nov 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2017 | Amount | Grant - CorMedix | Valuation |
investors |
|
| Oct, 2013 | Amount | Post-IPO - CorMedix | Valuation |
investors |
|
| Nov, 2009 | Amount | Seed - CorMedix | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CorMedix
CorMedix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CorMedix
CorMedix has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Melinta Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of bacterial ribosome-targeting drugs for MDR infections
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - CorMedix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cormedix Comparisons
Competitors of CorMedix
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cormedix
Frequently Asked Questions about CorMedix
When was CorMedix founded?
CorMedix was founded in 2006 and raised its 1st funding round 3 years after it was founded.
Where is CorMedix located?
CorMedix is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
Is CorMedix a funded company?
CorMedix is a funded company, having raised a total of $2.62M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.62M, raised on Nov 12, 2009.
How many employees does CorMedix have?
As of Dec 31, 2024, the latest employee count at CorMedix is 65.
What is the annual revenue of CorMedix?
Annual revenue of CorMedix is $43.47M as on Dec 31, 2024.
What does CorMedix do?
CorMedix was founded in 2006 as a biopharmaceutical company based in Bridgewater, United States. Therapeutic products are in-licensed, developed, and commercialized to address cardiac, renal, and infectious diseases. Operations center on Neutrolin, a solution designed to prevent infection, thrombosis, and biofilm in catheters for oncology, hemodialysis, and intensive care patients. CE approval has been obtained in Europe, with distribution planned for the United States, Middle East, South America, and Africa.
Is CorMedix publicly traded?
Yes, CorMedix is publicly traded on NASDAQ under the ticker symbol CRMD.
How many acquisitions has CorMedix made?
CorMedix has made 1 acquisition, including Melinta Therapeutics.
Who are CorMedix's investors?
CorMedix has 1 investor. Key investors include HHS.
What is CorMedix's ticker symbol?
The ticker symbol of CorMedix is CRMD on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.